PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE
Provided is a pharmaceutical composition comprising as active ingredients: 5mg of tadalafil or a pharmaceutically acceptable salt thereof; and 0.5 mg of dutasteride or a pharmaceutically acceptable salt thereof, wherein the dissolution rate of tadalafil under the dissolution conditions of a paddle r...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided is a pharmaceutical composition comprising as active ingredients: 5mg of tadalafil or a pharmaceutically acceptable salt thereof; and 0.5 mg of dutasteride or a pharmaceutically acceptable salt thereof, wherein the dissolution rate of tadalafil under the dissolution conditions of a paddle rate of 50 rpm in 500 mL of a dissolution solution having a pH of 1.2 and containing 0.25% of SLS is 60-75% after 5 minutes and 80% or more after 30 minutes, and the dissolution rate of dutasteride under the dissolution conditions of a paddle rate of 50 rpm in 500 mL of a dissolution solution containing water and 0.1% of SLS is 50% or more after 15 minutes and 85% or more after 30 minutes.
L'invention concerne une composition pharmaceutique comprenant en tant que principes actifs : 5 mg de tadalafil ou un sel pharmaceutiquement acceptable de celui-ci ; et 0,5 mg de dutastéride ou d'un sel pharmaceutiquement acceptable de celui-ci, le taux de dissolution du tadalafil dans les conditions de dissolution d'une vitesse de pales de 50 tours/minute dans 500 mL d'une solution de dissolution ayant un pH de 1,2 et contenant 0,25 % de SLS étant de 60 à 75 % après 5 minutes et 80 % ou plus après 30 minutes et la vitesse de dissolution de dutastéride dans les conditions de dissolution d'une vitesse de pales de 50 tours/minute dans 500 mL d'une solution de dissolution contenant de l'eau et 0,1 % de SLS étant de 50 % ou plus après 15 minutes et 85 % ou plus après 30 minutes.
타다라필 또는 이의 약제학적으로 허용되는 염 5mg; 두타스테리드 또는 이의 약제학적으로 허용되는 염 0.5mg을 유효성분으로 포함하는 약제학적 조성물에 있어서, pH 1.2, 0.25% SLS를 포함하는 용출액 500mL에서 패들속도를 50rpm으로 하는 용출조건에서 타다라필의 용출률이 5분에 60~75% 및 30분에 80%이상의 용출률, 및 물, 0.1% SLS를 포함하는 용출액 500mL에서 패들속도를 50 rpm으로 하는 용출조건에서 두타스테리드의 용출률이 15분에 50% 이상 및 30분에 85%이상의 용출률을 나타내는 것을 특징으로 하는 약제학적 조성물이 제공된다. |
---|